Doga Gulhan

14PUBLICATIONS
141CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 01, 2026
Correlation-aware discovery of co-occurring mutational signatures in cancer.

|Jul 29, 2026
Oxidized protein states define metastatic fitness in lung cancer.

|May 04, 2026
Topographical archetypes of somatic mutagenesis in cancer.

|Apr 17, 2026
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

|Jan 08, 2026
Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators.

Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel

|Nov 24, 2025
Tissue specificity and chromosomal alterations shape divergent immune programs in HRD tumors.

Doga C Gulhan, David Barras, Marco Mina

Pageof 3

Frequent Collaborators

9 joint publications

Peter J Park

3 joint publications

David Barras

3 joint publications

Hu Jin

3 joint publications

Benedikt Geiger